Fig 1.
Distribution of MPO-DNA complex levels among age categories.
*p<0.01. Data are presented as median and 25th-75th percentiles. Category 55–65 years, (n = 2286) MPO-DNA complex 56 mAU/mL (45–93), category 65–75 years (n = 2467) MPO-DNA complex 53 mAU/mL (41–83), category >75 years (n = 1674) MPO-DNA complex 52 AU/mL (41–81). Differences between age categories were analyzed using the Kruskall–Wallis test with post-hoc analysis.
Table 1.
Baseline characteristics of the total cohort.
Table 2.
Associations between MPO-DNA complex levels and clinical characteristics.
Table 3.
Associations between MPO-DNA complex and inflammatory and immunology markers in a subset of 1208 individuals of RS-I-3.